Sigma Solve Limited Reports IPO Fund Utilization Deviation for Q3 FY26
Sigma Solve Limited reported a deviation of ₹31.57 lakhs in its IPO fund utilization for Q3 FY26, reallocating unutilized public issue expenses to general corporate purposes. The company has utilized ₹265.45 lakhs out of total IPO proceeds of ₹495.45 lakhs raised in October 2020, with the deviation approved by shareholders in September 2022. The quarterly compliance report was reviewed by the Audit Committee and submitted to stock exchanges under SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Sigma Solve Limited has submitted its quarterly compliance report to the stock exchanges, disclosing deviations in the utilization of IPO proceeds for the quarter ended December 31, 2025. The filing, made under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was reviewed by the company's Audit Committee on January 13, 2026.
IPO Fund Utilization Overview
The company's IPO, conducted on October 15, 2020, raised ₹495.45 lakhs. The current quarter's report shows the utilization status across different objectives:
| Objective | Original Allocation (₹ Lakhs) | Funds Utilized (₹ Lakhs) | Deviation Amount (₹ Lakhs) |
|---|---|---|---|
| Acquisitions and Strategic Initiatives | 230.00 | Nil | Nil |
| Investment in Subsidiary | 70.00 | 70.00 | Nil |
| General Corporate Purpose | 120.00 | 120.00 | Nil |
| Public Issue Expenses | 75.45 | 75.45 | 31.57 |
| Total | 495.45 | 265.45 | 31.57 |
Shareholder-Approved Deviation
The reported deviation of ₹31.57 lakhs relates to unutilized funds from public issue expenses. The company obtained shareholder approval through a special resolution passed on September 19, 2022, at its 12th Annual General Meeting to reallocate this amount for general corporate purposes.
Quarterly Fund Status
The company confirmed that there has been no variation in the utilized amount of ₹265.45 lakhs compared to the previous quarter ended September 30, 2025. This amount covers:
- Investment in subsidiary operations
- Public issue expenses
- General corporate purposes
- Unutilized amount allocated for general corporate purposes
Regulatory Compliance
The deviation statement was signed by Managing Director Prakash Ratilal Parikh (DIN: 03019773) and submitted to both the National Stock Exchange of India Limited and BSE Limited. The company noted that no monitoring agency oversight applies to this fund utilization, and the Audit Committee provided no additional comments after its review.
The filing demonstrates Sigma Solve's adherence to regulatory disclosure requirements while managing its IPO proceeds in accordance with shareholder-approved modifications to the original fund utilization plan.
Historical Stock Returns for Sigma Solve
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.76% | -1.31% | +17.90% | -83.82% | +78.47% | +3,251.65% |
































